Uterine atony is the failure of the uterus to contract firmly after delivery, and it is the single most common cause of postpartum hemorrhage, accounting for up to about 80% of cases.1PubMed Central. Multiple Pregnancy and the Risk of Postpartum Hemorrhage: Retrospective Analysis in A Tertiary Level Center of Care During pregnancy the uterine muscle stretches to accommodate a growing baby, and after the placenta separates it needs to clamp down hard on the open blood vessels at the placenta’s former attachment site. When that clamping fails, bleeding can become life-threatening within minutes. The condition is treatable when caught quickly, but the speed of response matters enormously, and understanding who is at risk, how to prevent it, and how to escalate treatment when drugs alone don’t work can be the difference between a routine recovery and a catastrophe.
Why the Uterus Needs to Contract and What Goes Wrong
The placenta attaches to the inner wall of the uterus through a dense network of blood vessels that supply the baby throughout pregnancy. When the placenta detaches after birth, those vessels are essentially torn open. The body’s primary mechanism for stopping the resulting bleeding is not clotting alone; it is the physical compression of the uterine muscle fibers squeezing those vessels shut. Clinicians sometimes call this the “living ligature” because the muscle acts like a tourniquet from within. In uterine atony the muscle stays soft and boggy instead of firm, and blood continues to pour from the placental site with nothing to slow it down.
Postpartum hemorrhage is defined as blood loss of 500 mL or more after vaginal birth and 1,000 mL or more after cesarean, but the clinical reality is messier. Visual estimates of blood loss are notoriously inaccurate, and measured methods using graduated drapes or weighing of materials provide a better picture, though no single measurement approach has been shown to improve clinical outcomes on its own.2PubMed. Quantitative Blood Loss in Obstetric Hemorrhage: ACOG COMMITTEE OPINION, Number 794 Healthcare teams are increasingly encouraged to use quantitative measurement rather than guessing by eye, because eyeball estimates tend to undercount the true volume.3PubMed. Quantitative blood loss measurement methods for early detection of primary postpartum haemorrhage following vaginal birth: A scoping review
Who Is at Risk
A systematic review and meta-analysis of risk factors for atonic hemorrhage confirmed that the strongest predictors include a history of prior postpartum hemorrhage (of any cause), placenta previa, placental abruption, uterine rupture, and multiple gestation.4PubMed Central. Risk Factors for Atonic Postpartum Hemorrhage: A Systematic Review and Meta-analysis The common thread in several of these is uterine overdistension: the muscle has been stretched so far that it struggles to contract effectively afterward. Twins or higher-order multiples, excess amniotic fluid, and a large baby all push the uterus past its comfortable range.
A large study of vaginal deliveries identified additional independent risk factors, including preeclampsia, chorioamnionitis (infection of the membranes surrounding the baby), obesity, labor induction, anemia, and a prolonged second stage of labor.5PubMed Central. Risk Factors for Uterine Atony/Postpartum Hemorrhage Requiring Treatment after Vaginal Delivery Chorioamnionitis is a particularly sneaky contributor. Research on uterine contractility in women with suspected chorioamnionitis found that contractions held steady for about two hours after the onset of maternal fever but then progressively weakened, declining steadily despite continued oxytocin exposure. In that study, roughly a third of patients experienced postpartum hemorrhage requiring treatment.6PubMed. Suspected Chorioamnionitis and Myometrial Contractility: Mechanisms for Increased Risk of Cesarean Delivery and Postpartum Hemorrhage
While historically most cases of postpartum hemorrhage from atony followed vaginal delivery, recent data show a growing association between atonic hemorrhage and cesarean births.7Europe PMC. Physiology and Pathology of Contractility of the Myometrium The reasons include the surgical incision itself, the anesthetics used during the procedure, and the longer exposure to oxytocin that often precedes an unplanned cesarean.
Medications That Can Make It Worse
Some drugs given for legitimate medical reasons during pregnancy or labor can directly relax the uterine muscle, raising the risk of atony. Magnesium sulfate, commonly used to prevent seizures in preeclampsia, acts as a broad calcium blocker and interferes with the calcium-driven contraction machinery of the muscle. Nicardipine, a blood-pressure-lowering drug also used in preeclampsia, blocks a specific type of calcium channel. Volatile anesthetic gases used during general anesthesia for cesareans depress both spontaneous and oxytocin-driven contractions.8Maternal-Fetal Medicine. Magnesium Sulfate, Nicardipine, and Volatile Anesthetics in Severe Preeclampsia: Clinical and Mechanistic Implications for Uterine Atony and Postpartum Hemorrhage None of these drugs should be withheld when they are genuinely needed, but their use means the obstetric team should be on higher alert for atony and may need to act faster once bleeding begins.
Paradoxically, one of the most important drugs for treating atony, oxytocin, can also set the stage for it. When oxytocin is given for a prolonged period during labor induction or augmentation, the receptors on the uterine muscle cells become desensitized. The receptors internalize and uncouple from their signaling pathways, meaning that even more oxytocin later may not produce a strong contraction.9PubMed Central. Oxytocin exposure in women with postpartum hemorrhage secondary to uterine atony This is one of the reasons clinicians are advised to switch to a different class of uterotonic early when oxytocin alone isn’t working.10PubMed. Optimal uterotonic management
Prevention Through Active Management of the Third Stage
The third stage of labor is the interval between the birth of the baby and the delivery of the placenta. Active management of this stage, which typically involves giving a uterotonic drug (usually oxytocin) right around the time of delivery, gentle cord traction, and uterine massage, has been shown to reduce average blood loss and lower the likelihood of significant hemorrhage.11PubMed Central. Active versus expectant management for women in the third stage of labour Guidelines widely recommend offering active management to all women giving birth.12PubMed. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage
A study from Vietnam illustrated the real-world effect: when active management was introduced, the third stage was shorter, fewer women needed supplemental oxytocin or bimanual compression, and among women who had not received oxytocin earlier in labor, hemorrhage incidence dropped by about a third.13PubMed. Reducing postpartum hemorrhage in Vietnam: assessing the effectiveness of active management of third-stage labor Active management does not eliminate atony, but it significantly reduces how often it becomes a serious problem.
First-Line Treatment With Uterotonics
When atony develops despite prevention, the first response is a combination of uterine massage and additional oxytocin. A nurse or midwife will press firmly on the fundus (the top of the uterus through the abdominal wall) to stimulate contraction while ensuring the bladder is empty, because a full bladder can physically prevent the uterus from contracting. If the uterus stays boggy, additional uterotonics are given.
When oxytocin fails, clinicians reach for one of two main second-line agents: methylergonovine (an ergot alkaloid that causes sustained uterine contraction) or carboprost (a prostaglandin that does the same through a different pathway). A randomized trial comparing these head-to-head found no meaningful difference between them. Uterine tone scores at ten minutes were similar, the proportion of patients needing yet another drug was comparable (about 30-34%), and blood loss was roughly equivalent.14PubMed. Second-Line Uterotonics for Uterine Atony: A Randomized Controlled Trial Each agent carries different side effects and contraindications, so the choice between them is typically driven by the patient’s medical history rather than by one working better than the other. Methylergonovine raises blood pressure and is avoided in women with hypertensive disorders, while carboprost can trigger bronchospasm and is avoided in women with asthma.
Tranexamic acid, which works by stabilizing blood clots rather than by contracting the uterus, has emerged as an important adjunct regardless of the cause of hemorrhage. The large international WOMAN trial, which enrolled over 20,000 women, found that early administration reduced the risk of death from bleeding.15The Lancet. Effect of early tranexamic acid administration on death, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial The benefit was consistent across causes of bleeding, including atony, which makes tranexamic acid a useful tool to add early in the treatment sequence while other interventions are being prepared.
Mechanical and Procedural Options When Drugs Fall Short
If uterotonics don’t stop the bleeding, the next step is physical intervention. Bimanual uterine compression, where one hand is placed inside the uterus pressing against the lower segment while the other pushes down on the fundus through the abdomen, is the oldest and most immediately available technique. Research suggests this works better as a two-person technique, with one provider maintaining internal pressure and monitoring the patient while a second person applies external fundal pressure.16PubMed. Two-provider technique for bimanual uterine compression to control postpartum hemorrhage In settings with delayed access to surgical care, team-applied bimanual compression can buy critical time.
Intrauterine balloon tamponade is the next rung on the escalation ladder. A balloon catheter is inserted into the uterus and inflated with saline, pressing outward against the bleeding placental site. A retrospective study of the Bakri balloon found that when used early for atony specifically, the success rate reached 100%, compared with about 69% when used later or for mixed causes of hemorrhage.17PubMed. Success factors for Bakriā¢ balloon usage secondary to uterine atony: a retrospective, multicentre study Timing matters enormously with balloon tamponade; the earlier it goes in, the more likely it is to work.
A newer approach uses vacuum-induced hemorrhage control. Instead of pressing outward like a balloon, this device creates negative pressure (suction) inside the uterus, pulling the walls inward and collapsing the bleeding vessels. In a trial of 106 women treated with the device, the success rate was about 94%, and bleeding was controlled in a median of three minutes after the vacuum was connected.18PubMed Central. Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage A subsequent analysis of a larger dataset found that the device worked best when the cause was isolated atony, with a success rate above 92%, versus about 82% when atony was combined with other causes of bleeding.19PubMed Central. Predicting intrauterine vacuum-induced postpartum hemorrhage-control device treatment success
Surgical and Endovascular Rescue
When drugs and tamponade fail, surgery becomes necessary. The B-Lynch compression suture is a technique performed during cesarean or after opening the abdomen, in which a suture is placed around the uterus in a brace pattern that physically compresses it. This approach preserves the uterus and future fertility. Studies have reported success rates in the range of roughly 82% to 95%.20PubMed Central. B-Lynch Suture Management among Patients with Postpartum Hemorrhage in a Tertiary Care Centre: A Descriptive Cross-sectional Study21MGM Journal of Medical Sciences. Efficacy of B-Lynch compression suture for control of intractable hemorrhage during cesarean section In one study all women who received the suture retained their uterus, though in rare cases the bleeding returns hours later and further intervention becomes unavoidable.
Uterine artery embolization is a less invasive alternative that can be performed in a radiology suite. A catheter is threaded through the femoral artery up to the uterine arteries, and tiny particles are injected to block blood flow. A study of embolization for postpartum hemorrhage found a clinical success rate of about 85%, with atony being the most common reason for the procedure. The five patients who did not respond ultimately needed hysterectomy.22PubMed Central. Primary postpartum hemorrhage: outcome of uterine artery embolization Fertility appears to be preserved after embolization, though researchers have noted a higher rate of postpartum hemorrhage recurrence in subsequent pregnancies.23American Journal of Obstetrics & Gynecology. Is uterine artery embolization in postpartum hemorrhage due to uterine atony a fertility-sparing intervention?
Hysterectomy, the removal of the uterus, is the definitive last resort. It stops the bleeding with certainty but permanently ends the ability to carry a pregnancy. Across case series, uterine atony accounts for roughly 20-65% of emergency peripartum hysterectomies, with the wide range reflecting different populations and how aggressively other interventions are tried first.24PubMed Central. Emergency peripartum hysterectomy: Incidence, indications, risk factors and outcome25PubMed. Indication of emergency peripartum hysterectomy: review of 17 cases In one ten-year review at a single center, atony was the reason for hysterectomy in the majority of cases.26ISRN Emergency Medicine. Emergency Peripartum Hysterectomy: A 10-Year Review Every other intervention on the escalation ladder exists, in part, to make hysterectomy unnecessary.
The Psychological Aftermath
The physical emergency of postpartum hemorrhage is usually discussed in terms of blood loss and surgical outcomes, but the psychological toll is substantial and underappreciated. A mixed-methods systematic review of studies in high-income countries found that women who experienced postpartum hemorrhage were at elevated risk of post-traumatic stress disorder at every measured time point, from six weeks out to eight years after birth.27PLoS ONE. Primary postpartum haemorrhage and longer-term physical, psychological, and psychosocial health outcomes for women and their partners in high income countries: A mixed-methods systematic review In one study focused on women who had undergone uterine artery embolization for severe hemorrhage, about 22% met the threshold for PTSD an average of eight years later, compared to about 5% of controls. The association between hemorrhage and PTSD held even after adjusting for depression.28Scientific Reports. Paternal and maternal long-term psychological outcomes after uterine artery embolization for severe post-partum hemorrhage
Brief counseling provided within the first 48 to 72 hours after a hemorrhage event has shown promise for reducing PTSD symptoms. A quasi-experimental study found that intensive midwife-led counseling during this early window significantly lowered post-traumatic stress scores.29PubMed Central. Midwifery-led brief counseling on the severity of posttraumatic stress symptoms of postpartum hemorrhage: quasi-experimental study This is not yet standard practice everywhere, but it suggests that psychological follow-up should be part of the recovery plan, not an afterthought.
Sheehan Syndrome and Other Long-Term Physical Consequences
Severe hemorrhage from any cause, including atony, can starve the pituitary gland of blood. The pituitary, a small gland at the base of the brain, enlarges during pregnancy and becomes more vulnerable to damage from low blood pressure or shock. When pituitary tissue dies from inadequate blood flow, the result is Sheehan syndrome: a chronic condition in which the gland no longer produces enough hormones. Symptoms can include failure to produce breast milk, absent menstrual periods, fatigue, low blood pressure, and, over time, problems with thyroid and adrenal function.30PubMed Central. Sheehan’s syndrome: Newer advances Clinically significant Sheehan syndrome has become uncommon in settings with rapid access to transfusion and resuscitation, but it remains a concern in resource-limited environments where treatment of hemorrhage may be delayed.31PubMed. The incidence of Sheehan’s syndrome after obstetric hemorrhage
The Cold-Chain Problem and Heat-Stable Alternatives
Oxytocin is the backbone of both prevention and treatment of uterine atony worldwide, but it has a practical weakness: it needs refrigeration. In many low- and middle-income countries, reliable cold-chain storage is not available at every birth facility, and oxytocin that has been exposed to heat degrades and loses potency. A woman can receive the “right” drug and still bleed because the drug was stored at the wrong temperature.
Heat-stable carbetocin, an oxytocin analogue that remains effective for up to three years without refrigeration at temperatures up to 30Ā°C, has emerged as a potential solution. Large-scale trials demonstrated that it is clinically comparable to properly stored oxytocin. In a pilot program in Nigeria involving over 18,000 deliveries, facilities that used heat-stable carbetocin for hemorrhage prevention saw hemorrhage rates drop below 1%. Cost modeling from India estimated that at comparable pricing it could prevent roughly 5,500 additional hemorrhage cases and save five maternal lives per 100,000 births. Implementation programs in Kenya and South Sudan achieved over 90% coverage by combining WHO policy updates, pooled drug procurement, simulation training for health workers, and community education. In Kenya, awareness of uterotonics and hemorrhage warning signs among postpartum women rose from 48% to 81% after community-based outreach.32PubMed Central. Heat-Stable Carbetocin in the Management of Postpartum Haemorrhage in Low- and Middle-Income Countries: A Comprehensive Review of Clinical Evidence, Cost-Effectiveness, Implementation Challenges and Adoption Strategies The drug is not a magic bullet, but removing the cold-chain obstacle addresses one of the most frustrating logistical barriers to preventing atony-related deaths globally.